相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
Harald Sourij et al.
DIABETES OBESITY & METABOLISM (2021)
Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression
Timotius Ivan Hariyanto et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
Timotius Ivan Hariyanto et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis
Timotius Ivan Hariyanto et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2021)
Anosmia/Hyposmia is a Good Predictor of Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis
Timotius Ivan Hariyanto et al.
INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY (2021)
Dementia is a predictor for mortality outcome from coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Yuchen Chen et al.
DIABETES CARE (2020)
Exposure to dipeptidyl-peptidase-4 inhibitors andCOVID-19 among people with type 2 diabetes: A case-control study
Gian Paolo Fadini et al.
DIABETES OBESITY & METABOLISM (2020)
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou et al.
DIABETOLOGIA (2020)
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte et al.
ACTA DIABETOLOGICA (2020)
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Ines Valencia et al.
FRONTIERS IN PHARMACOLOGY (2020)
Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study
Huadong Yan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto et al.
DIGESTIVE AND LIVER DISEASE (2020)
Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
Laurie L. Baggio et al.
NATURE COMMUNICATIONS (2020)
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals
Hugo Zeberg et al.
NATURE (2020)
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review
Timotius Ivan Hariyanto et al.
Infectious Disorders - Drug Targets (2020)
Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China
Nan Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
Luis M. Perez-Belmonte et al.
BMC MEDICINE (2020)
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia A systematic review, meta analysis, and meta-regression
Ian Huang et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
Mi Kyung Kim et al.
DIABETES & METABOLISM JOURNAL (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Naveen Vankadari et al.
EMERGING MICROBES & INFECTIONS (2020)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank
Andrea V. Margulis et al.
CLINICAL EPIDEMIOLOGY (2014)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
分享论文
